Acute Leukemia Clinical Trials

211 clinical trials for Acute Leukemia across international registries, including 50 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Pathogenesis of Hematologic Malignancies — RECRUITING
• Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE1
• Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL) — RECRUITING · NA
• A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) — RECRUITING · PHASE1
• Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant — RECRUITING · PHASE2
• Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia — RECRUITING
• CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT — RECRUITING · NA
• Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies — RECRUITING · PHASE1
• Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders — RECRUITING · PHASE2
• A Study of Revumenib and Mezigdomide in People With Leukemia — RECRUITING · PHASE1
• Familial Investigations of Childhood Cancer Predisposition — RECRUITING
• Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies — RECRUITING · PHASE2
• Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing — RECRUITING · NA
• A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT — RECRUITING
• Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis — RECRUITING · NA
• MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases — RECRUITING · PHASE2
• Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia — RECRUITING · PHASE1
• BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) — RECRUITING · PHASE2
• MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies — RECRUITING · PHASE2
• Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT) — RECRUITING · NA
• Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia — RECRUITING · NA
• A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) — RECRUITING · PHASE1
• BY002 IIT Study in R/R Acute Leukemia — RECRUITING · PHASE1
• A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation — RECRUITING · PHASE2
• Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) — RECRUITING · PHASE2
• Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant — RECRUITING · PHASE1
• Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) — RECRUITING · NA
• Feasibility of a Multi-omics Platform for Hematological Malignancies — RECRUITING · NA
• INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) — RECRUITING · NA
• Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT) — RECRUITING · PHASE1
• A Phase 1/2, First-in-Human Study of theMenin-KMT2A (MLL1)Inhibitor Bleximenib in Participants with Acute Leukemia — RECRUITING · PHASE1
• Evaluation of the Efficacy of a Virtual Reality When Placing a Needle on an Implantable Venous Access Device in Children With Leukemia — RECRUITING · NA
• Umbilical Cord Blood Transplantation From Unrelated Donors — RECRUITING
• Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant — RECRUITING · PHASE2
• Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant — RECRUITING · PHASE2
• AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion — RECRUITING · PHASE2
• Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia — RECRUITING · PHASE2
• Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia — RECRUITING · PHASE2
• Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT — RECRUITING · PHASE2
• Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding — RECRUITING · NA
• Evaluation of Functional and Nutritional Parameters in Fit Acute Leukemia Patients — RECRUITING
• Study of the Immunological Infiltrate and Immunometabolic Immunometabolic Profile of Patients with Acute Leukaemia — RECRUITING
• The Effect of Serum Ferritin in irAE — RECRUITING · NA
• Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome — RECRUITING
• Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell in Patients With Relapsed/Refractory Acute Leukemia — RECRUITING · PHASE1
• Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction — RECRUITING
• Use of GnRHa During Chemotherapy for Fertility Protection — RECRUITING · PHASE3
• A Retrospective Study on the Relationship Between Donor Leukocyte Telomere Length and Prognosis of Acute Leukemia Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING
• Olverembatinib for FGFR1-rearranged Neoplasms — RECRUITING · PHASE2
• CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia — RECRUITING

Refine this search